Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 202.32 Million USD | -15.09% |
| 2022 | 238.27 Million USD | 29.15% |
| 2021 | 184.49 Million USD | 94.15% |
| 2020 | 95.02 Million USD | 73.3% |
| 2019 | 54.83 Million USD | 29.74% |
| 2018 | 42.26 Million USD | 8.36% |
| 2017 | 39 Million USD | 57.94% |
| 2016 | 24.69 Million USD | 37.22% |
| 2015 | 17.99 Million USD | 45.34% |
| 2014 | 12.38 Million USD | 4.96% |
| 2013 | 11.79 Million USD | 5.88% |
| 2012 | 11.14 Million USD | 470.31% |
| 2011 | 1.95 Million USD | -11.23% |
| 2010 | 2.2 Million USD | -8.79% |
| 2009 | 2.41 Million USD | -13.94% |
| 2008 | 2.8 Million USD | 85.15% |
| 2007 | 1.51 Million USD | 3.34% |
| 2006 | 1.46 Million USD | 131.42% |
| 2005 | 633.31 Thousand USD | -27.98% |
| 2004 | 879.38 Thousand USD | -1.18% |
| 2003 | 889.92 Thousand USD | -2.86% |
| 2002 | 916.09 Thousand USD | 44.33% |
| 2001 | 634.72 Thousand USD | 15.94% |
| 2000 | 547.44 Thousand USD | -8.76% |
| 1999 | 600 Thousand USD | -14.29% |
| 1998 | 700 Thousand USD | 40.0% |
| 1997 | 500 Thousand USD | -28.57% |
| 1996 | 700 Thousand USD | -41.67% |
| 1995 | 1.2 Million USD | -7.69% |
| 1994 | 1.3 Million USD | -31.58% |
| 1993 | 1.9 Million USD | 375.0% |
| 1992 | 400 Thousand USD | 0.0% |
| 1991 | 400 Thousand USD | 100.0% |
| 1990 | 200 Thousand USD | 100.0% |
| 1989 | 100 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 198.03 Million USD | -2.12% |
| 2024 Q2 | 190.52 Million USD | -3.79% |
| 2023 Q3 | 211.37 Million USD | -12.25% |
| 2023 Q1 | 244.7 Million USD | 2.7% |
| 2023 Q2 | 240.86 Million USD | -1.57% |
| 2023 FY | 202.32 Million USD | -15.09% |
| 2023 Q4 | 202.32 Million USD | -4.28% |
| 2022 Q4 | 238.27 Million USD | -1.82% |
| 2022 Q3 | 242.69 Million USD | 1.5% |
| 2022 Q1 | 213.77 Million USD | 15.87% |
| 2022 FY | 238.27 Million USD | 29.15% |
| 2022 Q2 | 239.11 Million USD | 11.85% |
| 2021 FY | 184.49 Million USD | 94.15% |
| 2021 Q1 | 109.52 Million USD | 15.25% |
| 2021 Q2 | 135.5 Million USD | 23.73% |
| 2021 Q3 | 156.16 Million USD | 15.24% |
| 2021 Q4 | 184.49 Million USD | 18.14% |
| 2020 Q3 | 78.53 Million USD | 12.3% |
| 2020 Q2 | 69.92 Million USD | 13.19% |
| 2020 Q1 | 61.78 Million USD | 12.67% |
| 2020 FY | 95.02 Million USD | 73.3% |
| 2020 Q4 | 95.02 Million USD | 21.0% |
| 2019 FY | 54.83 Million USD | 29.74% |
| 2019 Q4 | 54.83 Million USD | 6.31% |
| 2019 Q2 | 51.27 Million USD | 14.15% |
| 2019 Q1 | 44.92 Million USD | 6.29% |
| 2019 Q3 | 51.57 Million USD | 0.59% |
| 2018 Q3 | 42.28 Million USD | 3.26% |
| 2018 Q1 | 40.12 Million USD | 2.87% |
| 2018 FY | 42.26 Million USD | 8.36% |
| 2018 Q4 | 42.26 Million USD | -0.05% |
| 2018 Q2 | 40.94 Million USD | 2.05% |
| 2017 Q2 | 26.08 Million USD | 8.88% |
| 2017 Q1 | 23.95 Million USD | -2.99% |
| 2017 Q4 | 39 Million USD | 0.88% |
| 2017 FY | 39 Million USD | 57.94% |
| 2017 Q3 | 38.66 Million USD | 48.22% |
| 2016 Q3 | 24.46 Million USD | 5.46% |
| 2016 FY | 24.69 Million USD | 37.22% |
| 2016 Q4 | 24.69 Million USD | 0.95% |
| 2016 Q2 | 23.19 Million USD | 8.81% |
| 2016 Q1 | 21.31 Million USD | 18.45% |
| 2015 Q4 | 17.99 Million USD | 13.2% |
| 2015 Q1 | 12.23 Million USD | -1.19% |
| 2015 Q3 | 15.89 Million USD | 11.14% |
| 2015 Q2 | 14.3 Million USD | 16.92% |
| 2015 FY | 17.99 Million USD | 45.34% |
| 2014 Q4 | 12.38 Million USD | -7.18% |
| 2014 Q3 | 13.34 Million USD | 4.04% |
| 2014 FY | 12.38 Million USD | 4.96% |
| 2014 Q1 | 11.44 Million USD | -3.03% |
| 2014 Q2 | 12.82 Million USD | 12.08% |
| 2013 Q1 | 10.26 Million USD | -7.89% |
| 2013 FY | 11.79 Million USD | 5.88% |
| 2013 Q2 | 10.55 Million USD | 2.86% |
| 2013 Q3 | 10.06 Million USD | -4.68% |
| 2013 Q4 | 11.79 Million USD | 17.24% |
| 2012 Q1 | 13.84 Million USD | 0.0% |
| 2012 Q2 | 11.5 Million USD | -16.92% |
| 2012 Q3 | 10.76 Million USD | -6.39% |
| 2012 Q4 | 11.14 Million USD | 3.49% |
| 2012 FY | 11.14 Million USD | 470.31% |
| 2011 Q1 | 1.95 Million USD | 0.85% |
| 2011 Q2 | 2.69 Million USD | 37.81% |
| 2011 Q3 | 2.46 Million USD | -8.64% |
| 2011 FY | 1.95 Million USD | -11.23% |
| 2010 Q1 | 2.2 Million USD | 4.64% |
| 2010 FY | 2.2 Million USD | -8.79% |
| 2010 Q4 | 1.93 Million USD | -4.87% |
| 2010 Q3 | 2.03 Million USD | -8.19% |
| 2010 Q2 | 2.21 Million USD | 0.8% |
| 2009 Q4 | 2.1 Million USD | -7.52% |
| 2009 FY | 2.41 Million USD | -13.94% |
| 2009 Q1 | 2.41 Million USD | -4.31% |
| 2009 Q2 | 2.17 Million USD | -9.67% |
| 2009 Q3 | 2.27 Million USD | 4.34% |
| 2008 Q2 | 2.46 Million USD | -11.93% |
| 2008 FY | 2.8 Million USD | 85.15% |
| 2008 Q1 | 2.8 Million USD | 83.92% |
| 2008 Q3 | 2.59 Million USD | 5.06% |
| 2008 Q4 | 2.52 Million USD | -2.8% |
| 2007 FY | 1.51 Million USD | 3.34% |
| 2007 Q1 | 1.51 Million USD | 39.0% |
| 2007 Q2 | 1.63 Million USD | 7.7% |
| 2007 Q4 | 1.52 Million USD | -8.55% |
| 2007 Q3 | 1.66 Million USD | 2.21% |
| 2006 Q2 | 1.24 Million USD | -15.32% |
| 2006 Q4 | 1.08 Million USD | 12.48% |
| 2006 Q1 | 1.46 Million USD | 7.19% |
| 2006 FY | 1.46 Million USD | 131.42% |
| 2006 Q3 | 968.74 Thousand USD | -21.94% |
| 2005 Q2 | 396.65 Thousand USD | -37.37% |
| 2005 FY | 633.31 Thousand USD | -27.98% |
| 2005 Q1 | 633.31 Thousand USD | -8.1% |
| 2005 Q4 | 1.36 Million USD | 121.6% |
| 2005 Q3 | 617.01 Thousand USD | 55.56% |
| 2004 Q2 | 636.84 Thousand USD | -27.58% |
| 2004 Q3 | 805.62 Thousand USD | 26.5% |
| 2004 Q4 | 689.14 Thousand USD | -14.46% |
| 2004 FY | 879.38 Thousand USD | -1.18% |
| 2004 Q1 | 879.38 Thousand USD | -13.26% |
| 2003 Q4 | 1.01 Million USD | 33.25% |
| 2003 Q3 | 760.84 Thousand USD | 9.0% |
| 2003 FY | 889.92 Thousand USD | -2.86% |
| 2003 Q1 | 889.92 Thousand USD | -14.02% |
| 2003 Q2 | 698 Thousand USD | -21.57% |
| 2002 Q4 | 1.03 Million USD | 14.88% |
| 2002 Q3 | 901 Thousand USD | -12.38% |
| 2002 Q2 | 1.02 Million USD | 12.24% |
| 2002 Q1 | 916.09 Thousand USD | 0.3% |
| 2002 FY | 916.09 Thousand USD | 44.33% |
| 2001 Q4 | 913.39 Thousand USD | -3.16% |
| 2001 Q3 | 943.16 Thousand USD | 3.47% |
| 2001 Q2 | 911.51 Thousand USD | 43.61% |
| 2001 Q1 | 634.72 Thousand USD | 12.2% |
| 2001 FY | 634.72 Thousand USD | 15.94% |
| 2000 Q3 | 549.88 Thousand USD | 1.27% |
| 2000 FY | 547.44 Thousand USD | -8.76% |
| 2000 Q2 | 543 Thousand USD | -0.81% |
| 2000 Q4 | 565.7 Thousand USD | 2.88% |
| 2000 Q1 | 547.44 Thousand USD | 9.49% |
| 1999 Q4 | 500 Thousand USD | 0.0% |
| 1999 Q2 | 600 Thousand USD | 0.0% |
| 1999 Q1 | 600 Thousand USD | -14.29% |
| 1999 FY | 600 Thousand USD | -14.29% |
| 1999 Q3 | 500 Thousand USD | -16.67% |
| 1998 FY | 700 Thousand USD | 40.0% |
| 1998 Q1 | 700 Thousand USD | 40.0% |
| 1998 Q2 | 700 Thousand USD | 0.0% |
| 1998 Q3 | 700 Thousand USD | 0.0% |
| 1998 Q4 | 700 Thousand USD | 0.0% |
| 1997 Q1 | 500 Thousand USD | 25.0% |
| 1997 Q4 | 500 Thousand USD | -16.67% |
| 1997 Q3 | 600 Thousand USD | 20.0% |
| 1997 Q2 | 500 Thousand USD | 0.0% |
| 1997 FY | 500 Thousand USD | -28.57% |
| 1996 FY | 700 Thousand USD | -41.67% |
| 1996 Q2 | 500 Thousand USD | -28.57% |
| 1996 Q3 | 600 Thousand USD | 20.0% |
| 1996 Q4 | 400 Thousand USD | -33.33% |
| 1996 Q1 | 700 Thousand USD | -41.67% |
| 1995 Q1 | 1.2 Million USD | -14.29% |
| 1995 Q2 | 1.5 Million USD | 25.0% |
| 1995 Q4 | 1.2 Million USD | -7.69% |
| 1995 Q3 | 1.3 Million USD | -13.33% |
| 1995 FY | 1.2 Million USD | -7.69% |
| 1994 FY | 1.3 Million USD | -31.58% |
| 1994 Q3 | 1.7 Million USD | 6.25% |
| 1994 Q4 | 1.4 Million USD | -17.65% |
| 1994 Q1 | 1.3 Million USD | -38.1% |
| 1994 Q2 | 1.6 Million USD | 23.08% |
| 1993 Q1 | 1.9 Million USD | 375.0% |
| 1993 Q2 | 2.6 Million USD | 36.84% |
| 1993 Q3 | 2.6 Million USD | 0.0% |
| 1993 FY | 1.9 Million USD | 375.0% |
| 1993 Q4 | 2.1 Million USD | -19.23% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 FY | 400 Thousand USD | 0.0% |
| 1992 Q4 | 400 Thousand USD | 0.0% |
| 1992 Q1 | 400 Thousand USD | 33.33% |
| 1992 Q2 | 400 Thousand USD | 0.0% |
| 1991 Q1 | 400 Thousand USD | 0.0% |
| 1991 FY | 400 Thousand USD | 100.0% |
| 1991 Q2 | 400 Thousand USD | 0.0% |
| 1991 Q3 | 400 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | -25.0% |
| 1990 FY | 200 Thousand USD | 100.0% |
| 1990 Q1 | 200 Thousand USD | 0.0% |
| 1990 Q2 | 200 Thousand USD | 0.0% |
| 1990 Q4 | 400 Thousand USD | 33.33% |
| 1990 Q3 | 300 Thousand USD | 50.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | 100 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -1031.739% |
| AngioDynamics, Inc. | 60.61 Million USD | -233.775% |
| AtriCure, Inc. | 67.89 Million USD | -197.982% |
| Avinger, Inc. | 5.29 Million USD | -3718.818% |
| Azenta, Inc. | 128.19 Million USD | -57.819% |
| BioLife Solutions, Inc. | 43.45 Million USD | -365.577% |
| The Cooper Companies, Inc. | 735.6 Million USD | 72.496% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -3906.356% |
| Femasys Inc. | 667.11 Thousand USD | -30227.618% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -718.583% |
| Hologic, Inc. | 679.8 Million USD | 70.238% |
| ICU Medical, Inc. | 709.36 Million USD | 71.478% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 83.424% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -5711.649% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -286.603% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -23514.692% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -23514.692% |
| Masimo Corporation | 545 Million USD | 62.877% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -12410.38% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 33.419% |
| Nephros, Inc. | 2.47 Million USD | -8091.134% |
| NovoCure Limited | 38.15 Million USD | -430.302% |
| NEXGEL, Inc. | 1.31 Million USD | -15238.969% |
| NEXGEL, Inc. | 1.31 Million USD | -15238.969% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -1390.724% |
| OraSure Technologies, Inc. | 47.61 Million USD | -324.919% |
| Pro-Dex, Inc. | 15.26 Million USD | -1225.044% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -40824.685% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -6954.182% |
| QuidelOrtho Corporation | 577.8 Million USD | 64.984% |
| Sanara MedTech Inc. | 4.71 Million USD | -4188.703% |
| STAAR Surgical Company | 35.13 Million USD | -475.921% |
| Sharps Technology, Inc. | 1.7 Million USD | -11737.625% |
| Utah Medical Products, Inc. | 9.58 Million USD | -2011.469% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 67.577% |
| Jin Medical International Ltd. | 5.05 Million USD | -3903.87% |